Similarly, IL-13 plays a role in anti-tumour immune responses; however, it may inhibit anti-tumour immunity by suppressing IFN-γ secretion, which promotes Th1 responses and CD8+ cytotoxic T lymphocyte activity [110]. This evidence concerns the gene IFNG and neoplasm.